Alpha Cognition (ACOG) Capital Expenditures (2025)

Alpha Cognition's (ACOG) quarterly Capital Expenditures came in at $147523.0 in Q4 2025, up 98.33% quarter-over-quarter from $74381.0 in Q3 2025.

Alpha Cognition (ACOG) Capital Expenditures (2025) Analysis & Trends

Alpha Cognition's Capital Expenditures history runs 1 years deep, the most recent figure standing at $147523.0 for Q4 2025.

On a quarterly basis, Capital Expenditures changed N/A year-over-year to $147523.0 in Q4 2025; TTM through Dec 2025 was $293489.0, a N/A change from a year earlier, with the FY2025 full-year figure at $293489.0, up 999.17% from the prior year.
Capital Expenditures grew to $147523.0 in Q4 2025 per ACOG's latest filing, from $74381.0 in the prior quarter.
Across five years, Capital Expenditures topped out at $147523.0 in Q4 2025 and bottomed at $8315.0 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Capital Expenditures (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-8,939.03
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	43.25 Mn
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	133.40 Mn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	230.60 Mn
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	786,000.00
10	Alpha Cognition	145.51 Mn	79.41 Mn	2.61 Mn	147,523.00

Download Data